cbdMD (YCBD) Total Current Liabilities (2016 - 2025)
cbdMD (YCBD) reported Total Current Liabilities of $2.8 million for Q4 2025, down 69.75% on a YoY basis from $9.2 million in Q4 2024, and down 13.14% sequentially from $3.2 million in Q3 2025.
cbdMD (YCBD) Total Current Liabilities (2016 - 2025) Analysis & Trends
cbdMD (YCBD) has 10 years of Total Current Liabilities data on file, last reported at $2.8 million in Q4 2025.
- For the quarter ending Q4 2025, Total Current Liabilities fell 69.75% year-over-year to $2.8 million; the trailing twelve-month figure through Dec 2025 stood at $2.8 million (down 69.75% YoY), and the FY2025 full-year result was $3.2 million, down 62.94% from the prior year.
- Total Current Liabilities retreated to $2.8 million in Q4 2025, from $3.2 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $9.9 million in Q1 2025 to a low of $2.8 million in Q4 2025.
- A 5-year average of $6.1 million and a median of $5.9 million in 2022 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities surged 84.53% in 2024 and plunged 69.75% in 2025, its largest moves.
- Tracing YCBD's Total Current Liabilities over 5 years: stood at $6.8 million in 2021, then retreated by 17.87% to $5.6 million in 2022, then advanced by 7.55% to $6.0 million in 2023, then soared by 53.55% to $9.2 million in 2024, then sank by 69.75% to $2.8 million in 2025.
- Business Quant data shows YCBD's Total Current Liabilities at $2.8 million in Q4 2025, $3.2 million in Q3 2025, and $3.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | 2.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.77 Mn |
| Sep 30, 2025 | 3.19 Mn |
| Jun 30, 2025 | 3.58 Mn |
| Mar 31, 2025 | 9.87 Mn |
| Dec 31, 2024 | 9.17 Mn |
| Sep 30, 2024 | 8.62 Mn |
| Jun 30, 2024 | 7.86 Mn |
| Mar 31, 2024 | 6.94 Mn |
| Dec 31, 2023 | 5.97 Mn |
| Sep 30, 2023 | 4.67 Mn |
| Jun 30, 2023 | 4.38 Mn |
| Mar 31, 2023 | 4.68 Mn |
| Dec 31, 2022 | 5.55 Mn |
| Sep 30, 2022 | 5.29 Mn |
| Jun 30, 2022 | 5.73 Mn |
| Mar 31, 2022 | 5.79 Mn |
| Dec 31, 2021 | 6.76 Mn |
| Sep 30, 2021 | 6.92 Mn |
| Jun 30, 2021 | 6.75 Mn |
| Mar 31, 2021 | 6.86 Mn |